婴儿口服脊髓灰质炎1型疫苗的人体感染剂量测定
Human infective dose determinations for oral poliovirus type 1 vaccine in infants.
作者信息
Minor T E, Allen C I, Tsiatis A A, Nelson D B, D'Alessio D J
出版信息
J Clin Microbiol. 1981 Feb;13(2):388-9. doi: 10.1128/jcm.13.2.388-389.1981.
Abstract
The 50, 10, and 1% human infective doses of poliovirus type 1 vaccine administered orally to 32 infants were estimated to be 72, 39, and 20 tissue culture infective doses, respectively.
摘要
对32名婴儿口服1型脊髓灰质炎病毒疫苗，其50%、10%和1%的人感染剂量估计分别为72、39和20个组织培养感染剂量。
相似文献
1
Human infective dose determinations for oral poliovirus type 1 vaccine in infants.婴儿口服脊髓灰质炎1型疫苗的人体感染剂量测定
J Clin Microbiol. 1981 Feb;13(2):388-9. doi: 10.1128/jcm.13.2.388-389.1981.
2
Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.在泰国婴儿中同时口服恒河猴-人重配四价（RRV-TV）轮状病毒疫苗和口服脊髓灰质炎病毒疫苗（OPV）。
Vaccine. 1995 Feb;13(2):168-74. doi: 10.1016/0264-410x(95)93131-r.
3
Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines.既往免疫对口服减毒活脊髓灰质炎病毒疫苗后粪便中强毒回复株病毒排出的影响。
J Infect Dis. 1991 Jul;164(1):191-4. doi: 10.1093/infdis/164.1.191.
4
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.两种新型口服减毒单价（血清型 2）脊灰病毒疫苗在健康成年人中的安全性和免疫原性：一项双盲、单中心 1 期研究。
Lancet. 2019 Jul 13;394(10193):148-158. doi: 10.1016/S0140-6736(19)31279-6. Epub 2019 Jun 4.
5
[Fecal excretion of poliovirus in subjects subjected to antipoliomyelitis vaccination].[接受抗脊髓灰质炎疫苗接种的受试者粪便中脊髓灰质炎病毒的排泄情况]
Nuovi Ann Ig Microbiol. 1982 Mar-Jun;33(2-3):285-94.
6
Excretion of live attenuated polioviruses in the faeces of orally vaccinated children. Comparison of two immunization schedules.
J Hyg Epidemiol Microbiol Immunol. 1985;29(2):211-8.
7
Trial of a supplemental dose of four poliovirus vaccines.四价脊髓灰质炎疫苗补充剂量试验。
N Engl J Med. 2000 Sep 14;343(11):767-73. doi: 10.1056/NEJM200009143431103.
8
Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S471-4. doi: 10.1093/clinids/6.supplement_2.s471.
9
Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.三种序贯灭活脊髓灰质炎病毒疫苗-减毒活口服脊髓灰质炎病毒疫苗免疫程序诱导婴儿的体液免疫和黏膜免疫。巴尔的摩地区脊髓灰质炎疫苗研究组。
J Infect Dis. 1997 Feb;175 Suppl 1:S228-34. doi: 10.1093/infdis/175.supplement_1.s228.
10
Poliovirus neutralising antibody in infants and cord blood.
Ann Acad Med Singap. 1993 May;22(3):281-5.
引用本文的文献
1
Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.通过食物和环境传播的主要人类呼吸道和肠道病毒的最小感染剂量
Food Environ Virol. 2011 Mar;3(1):1-30. doi: 10.1007/s12560-011-9056-7. Epub 2011 Mar 16.
2
Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.评估停用口服脊髓灰质炎疫苗后消灭脊灰的稳定性。
PLoS Biol. 2018 Apr 27;16(4):e2002468. doi: 10.1371/journal.pbio.2002468. eCollection 2018 Apr.
3
Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.先天宿主对病毒传播和种群多样性的屏障：从脊髓灰质炎病毒中吸取的教训。
Adv Virus Res. 2010;77:85-118. doi: 10.1016/B978-0-12-385034-8.00004-1.
4
New recognition of Enterovirus infections in bottlenose dolphins (Tursiops truncatus).宽吻海豚（Tursiops truncatus）肠道病毒感染的新认识。
Vet Microbiol. 2009 Oct 20;139(1-2):170-5. doi: 10.1016/j.vetmic.2009.05.010. Epub 2009 Jun 6.
5
The effect of ongoing exposure dynamics in dose response relationships.剂量反应关系中持续暴露动态的影响。
PLoS Comput Biol. 2009 Jun;5(6):e1000399. doi: 10.1371/journal.pcbi.1000399. Epub 2009 Jun 5.
6
Spread and prevention of some common viral infections in community facilities and domestic homes.社区设施和家庭中一些常见病毒感染的传播与预防
J Appl Microbiol. 2001 Jul;91(1):7-21. doi: 10.1046/j.1365-2672.2001.01364.x.
7
Survival and detection of rotaviruses on environmental surfaces in day care centers.日托中心环境表面轮状病毒的存活与检测
Appl Environ Microbiol. 1983 Oct;46(4):813-6. doi: 10.1128/aem.46.4.813-816.1983.
8
Elimination of viruses and indicator bacteria at each step of treatment during preparation of drinking water at seven water treatment plants.七家水处理厂在饮用水制备过程中各处理步骤对病毒和指示菌的去除情况。
Appl Environ Microbiol. 1985 Jun;49(6):1418-28. doi: 10.1128/aem.49.6.1418-1428.1985.
本文引用的文献
1
Clinical trials in infants of orally administered attenuated poliomyelitis viruses.口服减毒脊髓灰质炎病毒在婴儿中的临床试验。
Pediatrics. 1959 Jun;23(6):1041-62.
2
Present status of attenuated live-virus poliomyelitis vaccine.减毒活疫苗脊髓灰质炎疫苗的现状。
J Am Med Assoc. 1956 Dec 29;162(18):1589-96. doi: 10.1001/jama.1956.02970350005002.
3
Immunization against poliomyelitis with living attenuated virus.
Am J Trop Med Hyg. 1956 May;5(3):440-52. doi: 10.4269/ajtmh.1956.5.440.
4
Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus.脊髓灰质炎病毒减毒株的临床研究；用作儿童活病毒免疫方法。
J Am Med Assoc. 1956 Mar 17;160(11):954-66. doi: 10.1001/jama.1956.02960460032008.
5
Living attenuated poliomyelitis virus as an immunizing agent of man.减毒活脊髓灰质炎病毒作为人类免疫制剂
S Afr Med J. 1955 Oct 29;29(49):1134-42.
6
Minimal infective dose of attenuated poliovirus for man.人用减毒脊髓灰质炎病毒的最小感染剂量
Am J Public Health Nations Health. 1967 Oct;57(10):1837-40. doi: 10.2105/ajph.57.10.1837.
7
Counterimmunoelectrophoresis test for immunoglobulin M antibodies to group B coxsackievirus.B组柯萨奇病毒免疫球蛋白M抗体的对流免疫电泳试验
J Clin Microbiol. 1979 Apr;9(4):503-6. doi: 10.1128/jcm.9.4.503-506.1979.
Zotero 插件